Plasma ALS and Gal-3BP differentiate early from advanced liver fibrosis in MASLD patients

• मुख्य लेखकों: David Pérez Compte (लेखक), Lucas Etourneau (लेखक), Anne-Marie Hesse (लेखक), Alexandra Kraut (लेखक), Justine Barthelon (लेखक), Nathalie Sturm (लेखक), Hélène Borges (लेखक), Salomé Biennier (लेखक), Marie Courçon (लेखक), Marc de Saint Loup (लेखक), Victoria Mignot (लेखक), Charlotte Costentin (लेखक), Thomas Burger (लेखक), Yohann Couté (लेखक), Christophe Bruley (लेखक), Thomas Decaens (लेखक), Michel Jaquinod (लेखक), Jérôme Boursier (लेखक), Virginie Brun (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: BMC, 2024-04-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Abstract Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is estimated to affect 30% of the world's population, and its prevalence is increasing in line with obesity. Liver fibrosis is closely related to mortality, making it the most important clinical parameter for M...